DE69823638D1 - Oralprodukt zur Prävention und Behandlung von ansteckender Gastroenteritis in Kälbern - Google Patents

Oralprodukt zur Prävention und Behandlung von ansteckender Gastroenteritis in Kälbern

Info

Publication number
DE69823638D1
DE69823638D1 DE69823638T DE69823638T DE69823638D1 DE 69823638 D1 DE69823638 D1 DE 69823638D1 DE 69823638 T DE69823638 T DE 69823638T DE 69823638 T DE69823638 T DE 69823638T DE 69823638 D1 DE69823638 D1 DE 69823638D1
Authority
DE
Germany
Prior art keywords
bovine
calves
immunized
prevention
escherichia coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69823638T
Other languages
English (en)
Inventor
Petr Mican
Jan Stepanek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medipharm Cz S R O
Original Assignee
Medipharm Cz S R O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medipharm Cz S R O filed Critical Medipharm Cz S R O
Application granted granted Critical
Publication of DE69823638D1 publication Critical patent/DE69823638D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002—Coronaviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69823638T 1998-01-19 1998-12-15 Oralprodukt zur Prävention und Behandlung von ansteckender Gastroenteritis in Kälbern Expired - Lifetime DE69823638D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ98158A CZ15898A3 (cs) 1998-01-19 1998-01-19 Perorální přípravek k prevenci a léčbě infekčních gastroenteritid telat

Publications (1)

Publication Number Publication Date
DE69823638D1 true DE69823638D1 (de) 2004-06-09

Family

ID=5461318

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69823638T Expired - Lifetime DE69823638D1 (de) 1998-01-19 1998-12-15 Oralprodukt zur Prävention und Behandlung von ansteckender Gastroenteritis in Kälbern

Country Status (6)

Country Link
EP (1) EP0930316B1 (de)
AT (1) ATE266045T1 (de)
CZ (1) CZ15898A3 (de)
DE (1) DE69823638D1 (de)
PL (1) PL191765B1 (de)
SK (1) SK283053B6 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002339112B2 (en) * 2001-11-12 2007-10-11 Mars, Incorporated Foodstuff
KR100492492B1 (ko) * 2002-03-07 2005-05-31 주식회사 에그 바이오택 대장균(k88), 대장균(k99), 유행성설사병바이러스, 전염성위장염바이러스에 대한 복합특수면역단백질을 함유한 계란을 생산하는 방법 및 상기 방법으로 생산한 계란
US6866868B1 (en) 2003-09-15 2005-03-15 4Life Research, Lc Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
EP1857116A1 (de) * 2006-05-19 2007-11-21 Novoplant GmbH Antigen-bindende Polypeptide gegen Rindercoronavirus spike Glykoprotein (S2)
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US20220047646A1 (en) * 2019-02-26 2022-02-17 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract
WO2020143892A2 (fr) * 2020-04-28 2020-07-16 Lachlak Nassira Le pro biotique qui guérit les patients covid 19 par le transfert de l'immunité passive naturelle a partir des vaches immunisées.
WO2022011436A1 (en) * 2020-07-17 2022-01-20 Immuron Limited Methods of treating coronavirus infection with bovine-hyperimmune colostrum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657663B2 (ja) * 1988-08-12 1994-08-03 武彦 山本 多機能特異的抗体の製造方法
JPH08509965A (ja) * 1993-03-15 1996-10-22 ファーマ・パシフィック・ピーティーワイ・リミテッド 治療剤および治療方法
CA2291487A1 (en) * 1997-05-29 1998-12-03 New Zealand Pastoral Agriculture Research Institute Limited Processes for production of immunoglobulin a in milk

Also Published As

Publication number Publication date
SK171898A3 (en) 1999-08-06
CZ285883B6 (cs) 1999-11-17
ATE266045T1 (de) 2004-05-15
PL191765B1 (pl) 2006-06-30
PL330975A1 (en) 1999-08-02
EP0930316A1 (de) 1999-07-21
SK283053B6 (sk) 2003-02-04
EP0930316B1 (de) 2004-05-06
CZ15898A3 (cs) 1999-11-17

Similar Documents

Publication Publication Date Title
US5772999A (en) Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
Tsubokura et al. Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni‐infected chickens
DK317988A (da) Fremgangsmaade og praeparat til oegning af proteinindholdet i maelk i maelkeproducerende dyr
GB2013691A (en) IgG Preparations
DE69823638D1 (de) Oralprodukt zur Prävention und Behandlung von ansteckender Gastroenteritis in Kälbern
EP0955061A1 (de) Orales Produkt zur Vorbeugung und Therapie von gastroenterischen Infektionen bei Schweinen
KR880003632A (ko) 계란으로부터의 특이적항체함유재료 및 그 제조방법과 용도
US8828422B2 (en) Stabilized liquid egg material for extended shelf life
DK398683D0 (da) Fremgangsmade til fremstilling af antistoffer
ATE237355T1 (de) Biologisches produkt zur präventiven oder therapeutischen oralen verabreichung gegen parvovirosis im hund
US20210252148A1 (en) Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine
EP0593440A4 (de) Verwendung von honig als impfstoff.
WO1996010420A1 (en) Composition and treatment for hyperimmunization with non heat-killed bacteria
FR2694885B1 (fr) Procédé pour améliorer la croissance et la qualité des carcasses des animaux domestiques producteurs de viande, ensemble de vaccination et vaccins.
KR20020068937A (ko) 항 대장균, 살모넬라 엔테라이티디스, 살모넬라티피뮤리움 및 헬리코박터 피로리의 특수면역단백질을공유한 계란 생산방법 및 상기 생산방법으로 생산된 계란,난황 및 상기 항-혼합균 특수면역단백질을 함유한요구르트 및 아이스크림
JP2009173558A (ja) 抗イヌ歯周病組成物
DE3476968D1 (en) Vaccine and process for its preparation
Coleman Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
RU2134580C1 (ru) Способ лечения острых маститов у коров
IT1260334B (it) Box adatto per allevare vitelli durante i primi trentagiorni di vita componibile con altri uguali a mezzo di distanziali
TH4654A (th) สารจากไข่ที่มีแอนติบอดีจำเพาะ กรรมวิธีการผลิตและการใช้สารดังกล่าว
TH11375B (th) สารจากไข่ที่มีแอนติบอดีจำเพาะ กรรมวิธีการผลิตและการใช้สารดังกล่าว

Legal Events

Date Code Title Description
8332 No legal effect for de